drugset / Trial / NCT01687296

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

NCT01687296

Phase 3 Completed 261 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with oral prednisone administered for 7 days to Chinese pediatric and adolescent subjects (aged 4 to 16 years) with an acute exacerbation of asthma

Timeline

Start
2012-11-12
Primary completion
2013-06-01
Completion
2013-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 1 mg Inhaled
Comparator Prednisone Other / unclassified 1 mg/kg Oral
Background Salbutamol Unknown Inhaled

Indications